• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Bone metastases from hepatocellular carcinoma:clinical features and prognostic factors

    2017-10-09 01:35:57YangLuJinGenHuXiangJinLinandXiGongLi

    Yang Lu, Jin-Gen Hu, Xiang-Jin Lin and Xi-Gong Li

    Hangzhou, China

    Bone metastases from hepatocellular carcinoma:clinical features and prognostic factors

    Yang Lu, Jin-Gen Hu, Xiang-Jin Lin and Xi-Gong Li

    Hangzhou, China

    BACKGROUND: Bone metastases (BMs) from hepatocellular carcinoma (HCC) is an increasingly common disease in Asia. We assessed the clinical features, prognostic factors, and differences in outcomes related to BMs among patients with different treatments for HCC.

    METHODS: Forty-three consecutive patients who were diagnosed with BMs from HCC between January 2010 and December 2014 were retrospectively enrolled.e clinical features were identified, the impacts of prognostic factors on survival were statistically analyzed, and clinical data were compared.RESULTS:e median patient age was 54 years; 38 patients were male and 5 female.e most common site for BMs was the trunk (69.3%). BMs with extension to the sotissue were found in 14 patients (32.5%). Most (90.7%) of the lesions were mixed osteolytic and osteoblastic, and most (69.8%) patients presented with multiple BMs.e median survival aer BMs diagnosis was 11 months. In multivariate analyses, survival aer BM diagnosis was correlated with Karnofsky performance status (P=0.008) and the Child-Pugh classification(P<0.001); BM-free survival was correlated with progression beyond the University of California San Francisco criteria(P<0.001) and treatment of primary tumors (P<0.001). BMs with extension to sotissue were less common in liver transplantation patients. During metastasis, the control of intrahepatic tumors was improved in liver transplantation and hepatectomy patients, compared to conservatively treated patients.

    (Hepatobiliary Pancreat Dis Int 2017;16:499-505)

    hepatocellular carcinoma;

    bone metastases;

    survival;

    prognostic factors

    Introduction

    Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer worldwide and the third leading cause of cancer-related death. HCC has a heterogeneous geographical distribution, with most cases (>80%) occurring in eastern Asia and sub-Saharan Africa.[1]Bone metastases (BMs) from HCC are highly vascularized lesions and cause severe deterioration of the patients' quality of life.e reported incidence of BM from HCC was relatively low before the 20th century.However, bone is now the second major site and accounts for approximately 25% of extrahepatic metastases from HCC.[2-4]is increase is due to the advances of bone imaging technique and the prolonged survival of HCC patients.[5-8]Hepatectomy, radiofrequency ablation, transhepatic arterial chemotherapy and embolization, and tyrosine kinase inhibitors such as sorafenib are effective treatment modalities for HCC.[9]Liver transplantation(LT) has also been established as a promising treatment for malignant liver diseases.[10-12]However, whether these treatments contribute towards the survival of patients with BMs from HCC, and whether they are related to the condition of patients during metastasis, remain unclear.In this study, the clinical features and prognostic factors were investigated in patients with BMs from HCC, and the clinical data were compared among patients with different treatments for intrahepatic tumors.

    Methods

    Study design

    We reviewed the data of 43 consecutive patients diagnosed with BMs from HCC in the First Affiliated Hospital, Zhejiang University School of Medicine betweenJanuary 2010 and December 2014. Sixteen patients underwent LT as treatment for HCC and subsequently developed BMs.e final follow-up date was June 30, 2015,and the median follow-up time was 11 months. None of the patients were enrolled in any clinical trials or experimental protocols.e Institutional Research Ethics Committee approved this retrospective observational study.

    All patients diagnosed with BMs from HCC were provided with histological confirmation of the disease via bone biopsy or surgical pathology.99mTc bone scintigraphy was used to locate all possible sites of BM.Magnetic resonance imaging (MRI) or computed tomography (CT) was performed to either confirm or provide detailed information on symptomatic sites.[13]Additional pretreatment evaluation included assessment of the patient's medical history, as well as a physical examination,complete blood routine, serum chemistries, blood gas analysis, alpha-fetoprotein (AFP) level, γ-glutamyl transpeptidase (γ-GT) level, chest X-ray, and abdominal and cardiac ultrasonography.

    Statistical analysis

    Clinical features were assessed based on descriptive statistics.e impact of prognostic factors on survival was analyzed by the Kaplan-Meier method and tested using the log-rank test. Median survivals were also calculated. Variables were entered using the Backward-Wald method in a Cox regression analysis (the level of statistical significance was set at aPvalue <0.05).e features of BMs in patients given different treatments were compared using Fisher's exact test (atP<0.017). All analyses and calculations were performed using the SPSS statistical soware (version 17.0; SPSS Inc., Chicago, IL, USA).

    Results

    Clinical features

    Of the 43 patients, 38 were male and 5 female, with a median age of 54 years (range 26-83). For the first BM-related event, 28 patients had pain (65.1%), 5 had dysneuria(11.6%), and 4 had a continuous rise in AFP levels (9.3%).Eight patients experienced no clinical symptoms, and their BMs were discovered by follow-up imaging studies of the HCC (18.6%). Five patients were diagnosed with BMs immediately aer HCC diagnosis (11.6%), and 38 developed BMs later on (88.4%).irty patients had multiple BMs (69.8%), 39 presented with mixed osteolytic and osteoblastic lesions (90.7%), 4 presented with purely osteolytic lesions (9.3%), and no patient had a purely osteoblastic lesion. BMs with extension to the sotissue were discovered in 14 patients (32.6%). Of the 101 BM sites, 69.3% were located on the trunk.e lumbar vertebrae (35.3%) were the most common responsible site, followed by the thoracic vertebrae (29.4%) (Table 1).

    Table 1.BM sites in the 43 HCC patients (n, %)

    All 43 patients were prescribed zoledronic acid.Twenty-two patients underwent palliative EBRT, 3 had curettage, 9 had curettage following EBRT, and 6 underwent wide resection following EBRT.e 1-year survivals for patients with EBRT, curettage, and wide resection were 40.9%, 50.0%, and 33.3%, respectively. Intraosseous recurrence occurred in one patient who had a wide resection.

    Outcomes

    Seven patients survived until the end offollow-up.Five of them had undergone LT and two had a hepatectomy for the treatment of the primary tumors, and their intrahepatic tumors remained under control since then.Five of these patients were treated with EBRT for BMs and two were treated with curettage. Causes of death included liver failure, tumor progression, or both in 33 patients (91.7%), pulmonary infection in 2 patients (5.6%),and stroke in 1 patient (2.8%).

    Table 2.Univariate analysis of predictors in 43 patients

    Fig. 1.Survival curves of different surgical modalities for BM.The survival after BM diagnosis was not significantly different(P=0.989).

    Fig. 2.Survival curves of different treatments for intrahepatic tumors.e treatment of the primary tumors significantly influenced the BM-free survival (P=0.002).

    BM-free survival

    Table 3.Comparison offactors among patients who underwent different treatments

    Comparison of patients with different treatments for intrahepatic tumors

    Discussion

    Due to an increased understanding of the interactions between metastatic tumor cells and the bone marrow microenvironment,[29]bone-targeted therapies such as zoledronic acid and denosumab have been used for the prevention of skeletal morbidities associated with malignant bone diseases, particularly in advanced-stage solid tumors arising from the breast, prostate, and multiple myeloma.[30-32]However, the efficiency of these treatments in patients with BMs from HCC has only been reported by several authors.[23,33]Sorafenib may improve patients' survival and affect bone metastasization,[34]but due to financial reasons, only two patients in the present study were treated with it and the treatment time was no longer than 3 months. We hope to recruit more patients treated with sorafenib and provide more clinical data in the future.

    Hematogenous spread through the pulmonary circulation or vertebral venous plexus is the paramount approach for the metastasization of HCC to bone.[36,37]Our work demonstrates that larger intrahepatic tumors (>5 cm in diameter) are a strong predictor for faster metastasization to bone. Furthermore, patients with multiple intrahepatic tumors had a poorer survival aer the diagnosis of BMs.e UCSF criteria and Hangzhou criteria are efficient methods for predicting survival in patients treated with LT,[15]factors that also predicted BM-free survival in this study. In fact, the death of patients with BMs from HCC is mainly due to liver failure or tumor progression.[38]erefore, follow-up examination and treatment of intrahepatic tumors should be thoroughly implemented.

    For patients with resectable HCC, surgery is the only proven potentially curative therapy.[9,39]Our work shows that the surgical removal of intrahepatic tumors helps to limit tumor metastasis. With the extensive use of LT in China, the number of LT patients with BMs is increasing in clinical practice. LT patients generally receive immunosuppressants, which will accelerate the recurrence or metastasization of tumors.[40,41]Previous studies have revealed that the presence of BMs is a contraindication for LT as well as an independent unfavorable prognostic factor for LT patients.[42,43]However, in this study, we found that LT patients had a longer BM-free survival and fol-lowed a trend for increased survival aer BM diagnosis,which means that LT is a favorable prognostic factor for BMs from HCC. We compared patients who underwent different treatments for HCC and found that LT patients had better intrahepatic tumor control and that fewer LT patients experienced extension to sotissue. We believe that the smaller tumor burden aer LT may have contributed towards this. Overall, the characteristics of HCC and the treatment of primary tumors were related to the speed of bone metastasization and the patient's prognosis.

    A limitation of this study was the small sample size and retrospective nature. Analyses of data on patients with different first BM-related events may introduce bias into the calculated survival intervals because there is a time lapse in diagnosis for patients who present to the hospital due to clinical symptoms compared to those whose BMs are discovered by periodic examination.Meanwhile, the retrospective nature makes it difficult to control the homogeneity of the extent of disease between patients undergoing different treatments.

    In conclusion, the independent prognostic factors of survival aer BM diagnosis were the KPS and Child-Pugh classification. HCC patients who went on to develop BMs may also benefit from LT or hepatectomy. A future study with a larger sample size, or a laboratory study into sotissue masses, should be conducted to better prove or illustrate the findings of this study and to explore potential therapeutic targets.

    Acknowledgements:We thank Division of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine for providing clinical data of primary tumors. We also thank Dr. Hong-Xun Zhou from University of Western Australia for advice on this article.

    Contributors:LXJ proposed the study. LY and HJG performed research and wrote the first dra. LY and HJG collected and analyzed the data. All authors contributed to the design and interpretation of the study to further dras. LY and HJG contributed equally to this study. LXJ is the guarantor.

    Funding:e study was supported by grants from Zhejiang Provincial Clinical Scientific Research Foundation of China(2013ZYC-A17), Ministry of Health of China (WKJ-ZJ-12) and Health Bureau of Zhejiang Province (2013KYB098).

    Ethical approval:is study was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012;142:1264-1273.

    2 Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y,Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2001;13:1083-1088.

    3 Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, et al. Hepatocellular carcinoma with extrahepatic metastasis:clinical features and prognostic factors. Cancer 2011;117:4475-4483.

    4 Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K,Sato T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781-1787.

    5 Ho CL, Chen S, Yeung DW, Cheng TK. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.J Nucl Med 2007;48:902-909.

    6 Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Cancer 2004;100:2415-2421.

    7 Yang BH, Xia JL, Huang LW, Tang ZY, Chen MS, Li JQ, et al. Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 2004;3:194-198.

    8 Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102:1661-1670.

    9 Ryder SD; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of hepatocellular carcinoma(HCC) in adults. Gut 2003;52:iii1-8.

    10 Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L.Survival aer liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897.

    11 Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV,Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005;241:905-918.

    12 Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 2016;65:1035-1041.

    13 Groves AM, Beadsmoore CJ, Cheow HK, Balan KK, Courtney HM, Kaptoge S, et al. Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Eur Radiol 2006;16:1066-1073.

    14 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A,Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.

    15 Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG,Ghobrial RM, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502-511.

    16 Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85:1726-1732.

    17 Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.

    18 Karnofsky DA. Nitrogen mustards in the treatment of neoplastic disease. Adv Intern Med 1950;4:1-75.

    19 Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A re-vised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186-2191.

    20 Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H,Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001;26:298-306.

    21 He J, Zeng ZC, Fan J, Zhou J, Sun J, Chen B, et al. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma aer liver transplantation.BMC Cancer 2011;11:492.

    22 He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, et al. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 2009;115:2710-2720.

    23 Santini D, Pantano F, Riccardi F, Di Costanzo GG, Addeo R,Guida FM, et al. Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. PLoS One 2014;9:e105268.

    24 Cho HS, Oh JH, Han I, Kim HS. Survival of patients with skeletal metastases from hepatocellular carcinoma aer surgical management. J Bone Joint Surg Br 2009;91:1505-1512.

    25 Hayashi S, Tanaka H, Hoshi H. Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma.World J Hepatol 2014;6:923-929.

    26 Seong J, Koom WS, Park HC. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int 2005;25:261-265.

    27 Kim SU, Kim DY, Park JY, Ahn SH, Nah HJ, Chon CY, et al.Hepatocellular carcinoma presenting with bone metastasis:clinical characteristics and prognostic factors. J Cancer Res Clin Oncol 2008;134:1377-1384.

    28 Manabe J, Kawaguchi N, Matsumoto S, Tanizawa T. Surgical treatment of bone metastasis: indications and outcomes. Int J Clin Oncol 2005;10:103-111.

    29 Buijs JT, van der Pluijm G. Osteotropic cancers: from primary tumor to bone. Cancer Lett 2009;273:177-193.

    30 Fizazi K, Carducci M, Smith M, Dami?o R, Brown J, Karsh L,et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011;377:813-822.

    31 Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 2011;29:1125-1132.

    32 Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 2010;28:5132-5139.

    33 Montella L, Addeo R, Palmieri G, Caraglia M, Cennamo G,Vincenzi B, et al. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series. Cancer Chemother Pharmacol 2010;65:1137-1143.

    34 Alemán JO, Farooki A, Girotra M. Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies. Endocr Relat Cancer 2014;21:R247-259.

    35 Liaw CC, Ng KT, Chen TJ, Liaw YF. Hepatocellular carcinoma presenting as bone metastasis. Cancer 1989;64:1753-1757.

    36 Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis:mechanisms and therapeutic opportunities. Nat Rev Endocrinol 2011;7:208-218.

    37 Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655-1664.

    38 Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H, et al. Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. Hepatogastroenterology 1997;44:251-257.

    39 Coleman RE. Bone cancer in 2011: Prevention and treatment of bone metastases. Nat Rev Clin Oncol 2011;9:76-78.

    40 Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl 2012;18:1277-1289.

    41 Zhang CX, Wen PH, Sun YL. Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance.Hepatobiliary Pancreat Dis Int 2015;14:470-476.

    42 Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM,Gondolesi GE, et al. Recurrence of hepatocellular carcinoma aer liver transplant: patterns and prognosis. Liver Transpl 2004;10:534-540.

    43 Shin WY, Suh KS, Lee HW, Kim J, Kim T, Yi NJ, et al. Prognostic factors affecting survival aer recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2010;16:678-684.

    December 21, 2015

    Accepted after revision September 30, 2016

    Author Affiliations: Department of Orthopedics, First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou 310003, China (Lu Y,Hu JG, Lin XJ and Li XG)

    Xiang-Jin Lin, MD, Department of Orthopedics,First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Tel/Fax: +86-571-87236848; Email: doclinxj@zju.edu.cn)? 2017, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(16)60173-X

    Published online January 25, 2017.

    毛片一级片免费看久久久久| 久久久精品免费免费高清| 只有这里有精品99| 97精品久久久久久久久久精品| 久久99热这里只频精品6学生| 日本午夜av视频| 欧美精品人与动牲交sv欧美| 久久国产精品男人的天堂亚洲 | 精品人妻一区二区三区麻豆| 91久久精品国产一区二区三区| 免费观看a级毛片全部| 色94色欧美一区二区| 午夜福利乱码中文字幕| 久久久久久人人人人人| 97在线视频观看| 黄片无遮挡物在线观看| 波野结衣二区三区在线| 日韩在线高清观看一区二区三区| 麻豆乱淫一区二区| 免费av中文字幕在线| 亚洲精品,欧美精品| 亚洲精品美女久久久久99蜜臀 | 99热国产这里只有精品6| 日本欧美视频一区| 青春草亚洲视频在线观看| 自线自在国产av| 亚洲国产欧美在线一区| 一级爰片在线观看| 国产精品三级大全| 纵有疾风起免费观看全集完整版| 久久人人爽人人片av| 国产一区二区在线观看av| 亚洲精品美女久久久久99蜜臀 | 美女国产高潮福利片在线看| 搡老乐熟女国产| 国产国语露脸激情在线看| 亚洲精品aⅴ在线观看| 亚洲精品一二三| 少妇人妻精品综合一区二区| 免费久久久久久久精品成人欧美视频 | 性色avwww在线观看| 亚洲国产精品一区三区| 汤姆久久久久久久影院中文字幕| 亚洲经典国产精华液单| 在线观看免费视频网站a站| 久久99热6这里只有精品| 免费看av在线观看网站| 老女人水多毛片| 一区二区日韩欧美中文字幕 | av福利片在线| 少妇的丰满在线观看| 国国产精品蜜臀av免费| 啦啦啦视频在线资源免费观看| 国语对白做爰xxxⅹ性视频网站| 久久久精品区二区三区| 亚洲国产精品国产精品| 欧美激情 高清一区二区三区| 免费观看av网站的网址| 中文字幕人妻熟女乱码| 美女xxoo啪啪120秒动态图| 国产老妇伦熟女老妇高清| 国产精品一国产av| 国产在线视频一区二区| 日韩在线高清观看一区二区三区| 国产又爽黄色视频| 亚洲国产精品国产精品| 亚洲国产成人一精品久久久| a级毛色黄片| 曰老女人黄片| 中文字幕精品免费在线观看视频 | 黑人巨大精品欧美一区二区蜜桃 | 18在线观看网站| 久久久久精品人妻al黑| 亚洲人与动物交配视频| 一级毛片我不卡| 国产成人免费无遮挡视频| 两个人看的免费小视频| 日本猛色少妇xxxxx猛交久久| 亚洲欧美成人综合另类久久久| 欧美精品人与动牲交sv欧美| 亚洲精品久久久久久婷婷小说| 国产成人精品婷婷| 国产男女内射视频| 在线观看免费高清a一片| 久久久精品区二区三区| 亚洲精品国产av成人精品| 嫩草影院入口| 侵犯人妻中文字幕一二三四区| 国产亚洲av片在线观看秒播厂| 国产精品蜜桃在线观看| 免费黄色在线免费观看| 99久久精品国产国产毛片| 毛片一级片免费看久久久久| 日本av手机在线免费观看| 中文字幕最新亚洲高清| 一级a做视频免费观看| xxx大片免费视频| av片东京热男人的天堂| 又大又黄又爽视频免费| 如日韩欧美国产精品一区二区三区| 日韩av在线免费看完整版不卡| 高清黄色对白视频在线免费看| 插逼视频在线观看| 国产成人精品在线电影| 黄色一级大片看看| 免费看光身美女| 少妇被粗大的猛进出69影院 | 最近中文字幕2019免费版| 国产精品.久久久| 亚洲国产日韩一区二区| 亚洲人成网站在线观看播放| 97精品久久久久久久久久精品| 卡戴珊不雅视频在线播放| 国产成人精品婷婷| 亚洲综合色网址| 777米奇影视久久| 免费不卡的大黄色大毛片视频在线观看| 久久精品久久久久久噜噜老黄| 男人操女人黄网站| 成人黄色视频免费在线看| 亚洲欧美成人综合另类久久久| 五月伊人婷婷丁香| 精品人妻偷拍中文字幕| 欧美激情极品国产一区二区三区 | 中文字幕最新亚洲高清| 久久午夜综合久久蜜桃| 国产视频首页在线观看| 久久ye,这里只有精品| 欧美另类一区| 中文字幕最新亚洲高清| 9色porny在线观看| 欧美日韩视频高清一区二区三区二| 亚洲国产精品一区三区| 天堂8中文在线网| 在线观看美女被高潮喷水网站| 青青草视频在线视频观看| 最近中文字幕高清免费大全6| 国精品久久久久久国模美| 精品少妇内射三级| av国产久精品久网站免费入址| 亚洲高清免费不卡视频| 美国免费a级毛片| 中文字幕精品免费在线观看视频 | 国产免费现黄频在线看| 在线精品无人区一区二区三| 国产欧美亚洲国产| 少妇高潮的动态图| 99精国产麻豆久久婷婷| 亚洲欧美一区二区三区黑人 | 在线看a的网站| 亚洲精品aⅴ在线观看| 一级,二级,三级黄色视频| 这个男人来自地球电影免费观看 | 亚洲综合精品二区| 午夜福利视频精品| 99九九在线精品视频| 午夜91福利影院| 99久久精品国产国产毛片| 国产精品一区www在线观看| 99热全是精品| 美女视频免费永久观看网站| 黑人巨大精品欧美一区二区蜜桃 | 亚洲国产精品专区欧美| 一本色道久久久久久精品综合| 国产成人精品婷婷| 精品一区在线观看国产| 亚洲国产精品一区三区| 色吧在线观看| 亚洲精品日韩在线中文字幕| 亚洲av中文av极速乱| 欧美日韩成人在线一区二区| 亚洲色图 男人天堂 中文字幕 | 国产av国产精品国产| 美女福利国产在线| 99九九在线精品视频| 欧美人与性动交α欧美软件 | 久久人妻熟女aⅴ| 国产永久视频网站| 国产黄色免费在线视频| 哪个播放器可以免费观看大片| 精品国产一区二区久久| 成人国产av品久久久| 久久这里只有精品19| 欧美bdsm另类| 亚洲国产av新网站| 欧美国产精品一级二级三级| 亚洲精品中文字幕在线视频| 日韩精品免费视频一区二区三区 | 欧美国产精品一级二级三级| 又粗又硬又长又爽又黄的视频| 亚洲内射少妇av| 一本色道久久久久久精品综合| 欧美精品国产亚洲| 国产精品欧美亚洲77777| 伦理电影免费视频| 制服人妻中文乱码| 久久97久久精品| 精品国产国语对白av| 春色校园在线视频观看| 我要看黄色一级片免费的| 女性被躁到高潮视频| 最近2019中文字幕mv第一页| 狂野欧美激情性bbbbbb| 亚洲五月色婷婷综合| 国产成人欧美| 亚洲精品一区蜜桃| 日本欧美视频一区| 少妇被粗大的猛进出69影院 | 边亲边吃奶的免费视频| 大香蕉久久成人网| 五月伊人婷婷丁香| 色婷婷av一区二区三区视频| 亚洲av福利一区| 亚洲欧洲精品一区二区精品久久久 | 精品一区二区三区四区五区乱码 | www.av在线官网国产| 国产男女超爽视频在线观看| 国产福利在线免费观看视频| 国产黄频视频在线观看| 久久这里只有精品19| 亚洲综合色网址| 精品第一国产精品| 久久韩国三级中文字幕| 国产亚洲精品久久久com| 日韩 亚洲 欧美在线| 黄色 视频免费看| 在线观看人妻少妇| 久久这里有精品视频免费| 国产xxxxx性猛交| 熟女av电影| 看十八女毛片水多多多| 国产免费一级a男人的天堂| 两性夫妻黄色片 | 免费大片18禁| 亚洲成人手机| a级毛片黄视频| 亚洲成人一二三区av| 亚洲伊人色综图| 午夜影院在线不卡| 欧美人与善性xxx| 一级毛片黄色毛片免费观看视频| 日产精品乱码卡一卡2卡三| 亚洲综合色惰| 国产综合精华液| 国内精品宾馆在线| 99热6这里只有精品| 深夜精品福利| 日韩伦理黄色片| 日日爽夜夜爽网站| 一边摸一边做爽爽视频免费| 国产在线一区二区三区精| 永久网站在线| 男女边吃奶边做爰视频| 成人二区视频| 99国产精品免费福利视频| 这个男人来自地球电影免费观看 | 丝袜在线中文字幕| 亚洲精品美女久久久久99蜜臀 | 视频区图区小说| 精品第一国产精品| 激情视频va一区二区三区| 捣出白浆h1v1| 亚洲人成网站在线观看播放| 最近中文字幕2019免费版| 美女国产视频在线观看| 久久午夜福利片| 飞空精品影院首页| 90打野战视频偷拍视频| 最新的欧美精品一区二区| 亚洲欧洲日产国产| 亚洲五月色婷婷综合| 亚洲,欧美精品.| 国产成人精品在线电影| 亚洲国产av新网站| 大片免费播放器 马上看| 蜜桃国产av成人99| 在线观看免费视频网站a站| 高清黄色对白视频在线免费看| 亚洲成国产人片在线观看| 国产免费视频播放在线视频| 久久精品夜色国产| 老女人水多毛片| 久久人妻熟女aⅴ| 国产男女内射视频| 亚洲国产色片| 91成人精品电影| 精品国产一区二区三区久久久樱花| 最黄视频免费看| 日日摸夜夜添夜夜爱| 亚洲精品456在线播放app| 国产欧美亚洲国产| 一区在线观看完整版| 国产免费视频播放在线视频| 亚洲精品国产av蜜桃| 国产成人一区二区在线| 在线观看免费日韩欧美大片| 黑人猛操日本美女一级片| 一二三四在线观看免费中文在 | 视频在线观看一区二区三区| 一边亲一边摸免费视频| 久久久精品区二区三区| 99精国产麻豆久久婷婷| 国产精品三级大全| 亚洲国产精品成人久久小说| 亚洲久久久国产精品| 欧美日韩视频精品一区| 日韩成人av中文字幕在线观看| 亚洲五月色婷婷综合| 精品少妇黑人巨大在线播放| 中文字幕人妻丝袜制服| 又大又黄又爽视频免费| 少妇猛男粗大的猛烈进出视频| 亚洲国产毛片av蜜桃av| 只有这里有精品99| 黄色毛片三级朝国网站| 午夜影院在线不卡| 免费高清在线观看视频在线观看| 亚洲色图综合在线观看| 国产一区有黄有色的免费视频| 日韩成人伦理影院| 制服丝袜香蕉在线| 欧美bdsm另类| 国产精品免费大片| videossex国产| 18禁观看日本| 亚洲三级黄色毛片| 满18在线观看网站| 久久久久精品久久久久真实原创| 黄片播放在线免费| 黄色 视频免费看| 精品人妻在线不人妻| 黄色配什么色好看| 亚洲人成77777在线视频| 亚洲色图 男人天堂 中文字幕 | 亚洲精品久久午夜乱码| 亚洲精品日本国产第一区| 久久久久精品人妻al黑| 最新的欧美精品一区二区| 黑人猛操日本美女一级片| 熟女人妻精品中文字幕| 久久精品aⅴ一区二区三区四区 | 国产日韩欧美在线精品| 夫妻性生交免费视频一级片| 菩萨蛮人人尽说江南好唐韦庄| av卡一久久| 丝瓜视频免费看黄片| 90打野战视频偷拍视频| 日本av免费视频播放| 国产高清国产精品国产三级| 国产精品久久久久久精品电影小说| videos熟女内射| 最近最新中文字幕大全免费视频 | 在线观看美女被高潮喷水网站| 秋霞在线观看毛片| 精品视频人人做人人爽| 午夜福利在线观看免费完整高清在| 亚洲成国产人片在线观看| 美女内射精品一级片tv| 久热久热在线精品观看| 久久亚洲国产成人精品v| a级毛片在线看网站| 99热网站在线观看| 啦啦啦视频在线资源免费观看| 性色av一级| 亚洲精品美女久久av网站| 免费观看a级毛片全部| 黄色毛片三级朝国网站| 久久精品国产a三级三级三级| 亚洲成人av在线免费| 七月丁香在线播放| 国产精品久久久久成人av| 精品一区二区三卡| 22中文网久久字幕| 中国国产av一级| 蜜桃国产av成人99| 岛国毛片在线播放| 精品久久久久久电影网| 一级毛片我不卡| 亚洲欧美色中文字幕在线| 亚洲欧美一区二区三区黑人 | 亚洲国产欧美在线一区| 曰老女人黄片| 97超碰精品成人国产| 亚洲精品,欧美精品| 一区二区三区四区激情视频| 国产黄色视频一区二区在线观看| 国产淫语在线视频| 日韩av不卡免费在线播放| 丰满迷人的少妇在线观看| 黄色 视频免费看| 免费高清在线观看日韩| 日韩三级伦理在线观看| 国产黄色视频一区二区在线观看| 色5月婷婷丁香| 又大又黄又爽视频免费| 欧美人与性动交α欧美软件 | 少妇人妻久久综合中文| 老司机影院成人| 亚洲精品一二三| 久久精品国产自在天天线| 人妻人人澡人人爽人人| 亚洲丝袜综合中文字幕| 国产黄色免费在线视频| 91在线精品国自产拍蜜月| 精品亚洲乱码少妇综合久久| 国产福利在线免费观看视频| 在线观看国产h片| 成年av动漫网址| 满18在线观看网站| 成人18禁高潮啪啪吃奶动态图| 纯流量卡能插随身wifi吗| 熟女电影av网| www.熟女人妻精品国产 | 亚洲精品久久久久久婷婷小说| 亚洲 欧美一区二区三区| 十八禁高潮呻吟视频| 中文天堂在线官网| 色视频在线一区二区三区| 十八禁高潮呻吟视频| 22中文网久久字幕| 91在线精品国自产拍蜜月| 免费黄频网站在线观看国产| 亚洲激情五月婷婷啪啪| 国精品久久久久久国模美| 久久久国产欧美日韩av| 视频在线观看一区二区三区| 久久 成人 亚洲| 亚洲三级黄色毛片| 国产精品一国产av| 精品久久久精品久久久| 国产又色又爽无遮挡免| 少妇人妻 视频| 9热在线视频观看99| 亚洲国产日韩一区二区| 精品午夜福利在线看| 欧美3d第一页| 熟女电影av网| 男女边吃奶边做爰视频| 中文字幕免费在线视频6| 男女下面插进去视频免费观看 | 国产精品久久久久久精品古装| 久久鲁丝午夜福利片| 中国三级夫妇交换| 人妻系列 视频| 伦理电影大哥的女人| 成人手机av| 99久久综合免费| 十八禁高潮呻吟视频| 性高湖久久久久久久久免费观看| 亚洲综合色网址| 飞空精品影院首页| 亚洲av日韩在线播放| 天美传媒精品一区二区| 日本91视频免费播放| 亚洲精品一区蜜桃| 欧美激情国产日韩精品一区| 久久久久视频综合| 国产乱来视频区| 久久久久久久久久人人人人人人| 男女高潮啪啪啪动态图| 国产在线一区二区三区精| 亚洲精品日韩在线中文字幕| 久久午夜福利片| 久久亚洲国产成人精品v| 成人国产av品久久久| 侵犯人妻中文字幕一二三四区| 国产精品一区二区在线观看99| 一级毛片电影观看| 亚洲精品一区蜜桃| 日韩一本色道免费dvd| 美女内射精品一级片tv| 97超碰精品成人国产| 一本—道久久a久久精品蜜桃钙片| 久久精品久久久久久久性| 免费女性裸体啪啪无遮挡网站| 国产成人av激情在线播放| 亚洲欧美色中文字幕在线| 欧美日韩精品成人综合77777| 亚洲欧美中文字幕日韩二区| 五月开心婷婷网| av天堂久久9| 国产精品久久久av美女十八| 成人黄色视频免费在线看| 欧美日韩av久久| 老司机影院毛片| 天堂8中文在线网| 成人综合一区亚洲| 国产麻豆69| 国产无遮挡羞羞视频在线观看| 国产福利在线免费观看视频| 久久韩国三级中文字幕| 18禁国产床啪视频网站| 日韩中文字幕视频在线看片| 三上悠亚av全集在线观看| 亚洲av国产av综合av卡| av不卡在线播放| 久久久国产精品麻豆| 国产精品一区二区在线不卡| 午夜福利视频在线观看免费| 成人黄色视频免费在线看| 丝袜脚勾引网站| 99国产综合亚洲精品| av在线播放精品| 亚洲欧美成人精品一区二区| 自拍欧美九色日韩亚洲蝌蚪91| 久久精品国产亚洲av天美| 中文欧美无线码| 国产成人aa在线观看| 99国产综合亚洲精品| 久久99热这里只频精品6学生| 亚洲丝袜综合中文字幕| 日本vs欧美在线观看视频| 超碰97精品在线观看| 母亲3免费完整高清在线观看 | 一级a做视频免费观看| 狠狠精品人妻久久久久久综合| 日产精品乱码卡一卡2卡三| 女性被躁到高潮视频| 国产男女超爽视频在线观看| 看免费av毛片| 18禁国产床啪视频网站| 大片电影免费在线观看免费| av黄色大香蕉| 久久精品久久久久久噜噜老黄| 一级黄片播放器| 人成视频在线观看免费观看| 婷婷色综合www| 国产精品一区二区在线观看99| 久久久久久久精品精品| 两个人免费观看高清视频| 精品午夜福利在线看| 亚洲少妇的诱惑av| 国产欧美日韩综合在线一区二区| 激情视频va一区二区三区| 久久免费观看电影| 久久久久网色| 亚洲第一区二区三区不卡| 男男h啪啪无遮挡| 看免费成人av毛片| 国产综合精华液| 亚洲精品一二三| 黑人猛操日本美女一级片| 久久狼人影院| 亚洲内射少妇av| 宅男免费午夜| 黄色毛片三级朝国网站| 美女脱内裤让男人舔精品视频| 国产免费视频播放在线视频| 捣出白浆h1v1| 日韩成人av中文字幕在线观看| 精品人妻熟女毛片av久久网站| 色视频在线一区二区三区| 在线精品无人区一区二区三| 亚洲精品久久午夜乱码| 国产成人一区二区在线| 国产视频首页在线观看| 亚洲人成网站在线观看播放| 欧美另类一区| 日韩一区二区视频免费看| 免费av中文字幕在线| 久久国产精品男人的天堂亚洲 | 久久精品夜色国产| 精品熟女少妇av免费看| 亚洲高清免费不卡视频| 人人妻人人爽人人添夜夜欢视频| 欧美少妇被猛烈插入视频| 亚洲国产精品国产精品| 国产熟女午夜一区二区三区| 国产精品久久久久久久久免| 国产国语露脸激情在线看| 国产精品久久久久久久久免| 亚洲色图 男人天堂 中文字幕 | 国产成人午夜福利电影在线观看| 日韩大片免费观看网站| 高清毛片免费看| 国产一区二区三区av在线| 亚洲人与动物交配视频| 久久99一区二区三区| 美国免费a级毛片| 女人久久www免费人成看片| 黄片播放在线免费| 久久毛片免费看一区二区三区| 高清av免费在线| 欧美精品高潮呻吟av久久| 亚洲国产av影院在线观看| 中文字幕免费在线视频6| 亚洲天堂av无毛| 国产69精品久久久久777片| 国产极品天堂在线| 亚洲人与动物交配视频| 欧美精品人与动牲交sv欧美| 午夜激情av网站| 亚洲精品乱码久久久久久按摩| 韩国av在线不卡| 制服诱惑二区| 久久久久久人妻| 国产成人免费观看mmmm| 国产一区有黄有色的免费视频| 国产成人精品婷婷| 久久这里有精品视频免费| 伦理电影免费视频| 欧美人与善性xxx| 啦啦啦视频在线资源免费观看| 国产成人精品在线电影| 亚洲综合精品二区| 午夜福利网站1000一区二区三区| 亚洲人与动物交配视频| 黄片无遮挡物在线观看| 亚洲精品国产av蜜桃| 七月丁香在线播放| 亚洲国产看品久久| 国产高清国产精品国产三级| 日本黄色日本黄色录像| 国产精品久久久久久av不卡| 全区人妻精品视频|